Publikationen

Baumgarten T, Lehmann F, Senff T, Slanina H, Schüttler CG, Walker A, Gerlich WH, Repp R, Timm J, Glebe D, Metzler M. Chronic Hepatitis B Virus Infection Acquired Under Cytostatic Treatment in Childhood - Clinical, Virological and Immunological Long-Term Follow-Up. J Viral Hepat. 2026 Jan;33(1):e70111. 

Gliga S, Böhm M, Lübke N, Killer A, Hüttig F, Haberl L, Timm J, Müller C, Heger E, Büch J, Fätkenheuer G, Lehmann C, Oette M, Hower M, Knechten H, Schübel N, Esser S, Schneeweiß S, Qurishi N, Römer K, Rockstroh JK, Kaiser R, Luedde T, Jensen BO; RESINA Study Group. 
HIV-1 virologic failure in the RESINA cohort: lessons from two decades of real-world data. Infection. 2025 Dec 17. doi: 10.1007/s15010-025-02713-7.

Rothhaar P, Arand T, Seong HG, Heuss C, Tulessin M, Wang Z, Förster C, Schneider AC, Quistrebert J, Chai H, Reineke M, Benning L, Honegger J, Hofmann M, Thimme R, Timm J; STOPHCV investigators; Schnitzler P, Merle U, Shoukry NH, Bruneau J, Rodrigo C, Lloyd A, Bull RA, Ansari MA, Mogler C, McLauchlan J, Forns X, Pérez-Del-Pulgar S, Lohmann V. Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease. Nat Commun. 2025 Dec 7;16(1):10948.

Duplessix T, Baermann BN, Hölscher AS, Tometten I, Schulz F, Munder S, Le DB, Jäger P, Nachtkamp K, Dietrich S, Timm J, Kobbe G, Lübke N. Early CMV DNAemia during letermovir prophylaxis predicts lower risk of late CMV infection and is associated with enhanced T-cell immunity after alloHSCT. Sci Rep. 2025 Nov 20;15(1):41154.

Helle M, Sorg UR, Ptok J, Thomas RE, Pracht K, Petzsch P, de Bruin A, Jäck H-M, Köhrer K, Degrandi D, Pfeffer K. Lymphotoxin beta receptor^-/- mice display altered B- and T-cell subpopulations in the bone marrow and peritoneal cavity after Toxoplasma gondii infection. Infect Immun. 2025 Oct 14;93(10):e0040825.

Hüsken S, Röder A, Ptok J, Meyer AE, Georg M, Schwarz Y, Roos C, Mätz-Rensing K, Hutter MC, Floss DM, Rettie AE, Girhard M, Hanenberg H, Wiek C. Functional analysis of CYP4B1 enzymes from apes and humans uncovers evolutionary hot spots for adaptations of the catalytical function. PLoS Genet. 2025 Jun 27;21(6):e1011750.

Vinikoor MJ, Walker A, Nsokolo B, Musonda T, Muula G, Michailidis E, Wandeler G, Alatrakchi N, Kelly P, Damagnez M, Le DB, Voges A, Lübke N, Kanunga A, Bosomprah S, Bhattacharya D, Chibundi C, Bwalya G, Musukuma-Chifulo K, Suslov A, Feuerherd M, Heim MH, Schwartz RE, Chung RT, Lauer G, Sinkala E, Timm J.  Whole-Genome Sequencing of Hepatitis B Virus Genotypes E and A in Zambia Reveals Limited Viral Diversity in HIV Coinfection. Open Forum Infect Dis. 2025 Oct 1;12(11):ofaf616. 

Le DB, Tometten I, Lübke N, Paluschinski M, Schupp AK, Ehlkes L, Kreuzer P, Zacharias N, Timm J, Dilthey A, Walker A. Whole-genome nanopore sequencing and automatic downstream analysis of respiratory syncytial virus using RSVTyper. Sci Rep. 2025 Oct 31;15(1):38101.

Bremer V, Scheiblauer H, Muenchhoff M, Schüttler C, Timm J, Baier M, Buder S, Meyer-Schlinkmann K, Neiße T, Dumke R, Meyer T, Steffen G, Jansen K, Brockmeyer N. [Point-of-care tests for sexually transmitted infections-what is the current status?]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025 Jun 5;68(10):1185-1193. [Article in German] 

Wetzke M, Le DB, Tometten I, Ritter S, Lübke N, Timm J, Dilthey A, Panning M, Walker A, Happle C.Prevalence of Resistance-Associated Mutations in RSV F Protein Against Monoclonal Antibodies Prior to Widespread Implementation: Findings From a Prospective German Pediatric Cohort. Influenza Other Respir Viruses. 2025 Sep;19(9):e70164. 

Schmidt K, Böhm S, Hesse R, Bock CT, Haller S, Katz K, Ross S, Timm J, Zimmermann R, Niendorf S. A healthcare-associated outbreak of hepatitis C virus infections attributable to tampering injectable anaesthetic opioids, South Germany, 2017-2018. Front Public Health. 2025 Sep 15;13:1589562.

Meister TL, Nocke MK, Heinen N, Burkard TL, Brüggemann Y, Westhoven S, Trüeb B, Ebert N, Thomann L, Lubieniecki KP, Lubieniecka JM, Döring K, Herrmann M, Haid S, Pietschmann T, Wiegmann B, Tao R, Pfefferle S, Addo MM, Thiel V, Drexler I, Babel N, Phuc Nguyen H, Brown RJP, Todt D, Steinmann E, Pfaender S. Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants. Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2500276122. 

Ptok J, Theiss S, Schaal H. Fully haplotyped genome assemblies of healthy individuals reveal variability in 5'ss strength and support by splicing regulatory proteins. NAR Genom Bioinform. 2025 Apr 4;7(2):lqaf036.

Dörnte C, Datsi A, Traska V, Kostyra J, Wagner M, Brauns O, Lamsfuß C, Winkels H, Balz V, Enczmann J, Adams O, Mueller L, Baurmann H, Eiz-Vesper B, Bonifacius A, Sorg RV, Dose C, Schmitz J, Richter A, Fischer J, Schuster M. Distinct HLA Haplotypes Are Associated With an Altered Strength of SARS-CoV-2-Specific T-Cell Responses and Unfavorable Disease Courses.  Eur J Immunol. 2025 Apr;55(4):e202451497.

Bremer V, Scheiblauer H, Muenchhoff M, Schüttler C, Timm J, Baier M, Buder S, Meyer-Schlinkmann K, Neiße T, Dumke R, Meyer T, Steffen G, Jansen K, Brockmeyer N. [Point-of-care tests for sexually transmitted infections-what is the current status?].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025 Jun 5. doi: 10.1007/s00103-025-04067-9. 

Killer A, Gliga S, Jensen BO, Park P, Lübke N, Walker A, Timm J, Luedde T, Bock HH. Functional Cure of Hepatitis B and D Coinfection After ART Nonadherence in a Person With HIV. J Med Virol. 2025 May;97(5):e70375. 

Översti S, Weber A, Baran V, Kieninger B, Dilthey A, Houwaart T, Walker A, Schneider-Brachert W, Kühnert D. Evolutionary and epidemic dynamics of COVID-19 in Germany exemplified by three Bayesian phylodynamic case studies. Bioinform Biol Insights. 2025 Mar 12;19:11779322251321065.

Hedberg P, Serwin K, Francesca Greco M, Pereira JPV, Juozapaite D, De Benedittis S, Bai F, Lübke N, Wienemann T, Fanti I, König F, Pfeifer N, Kaiser R, Zazzi M, Cozzi-Lepri A, Naumovas D, Marchetti G, Parczewski M, Jensen BO, Incardona F, Sönnerborg A, Nauclér P. Bacterial and viral co-infections in adult patients hospitalized with COVID-19 throughout the pandemic: A Multinational Cohort Study in the EuCARE Project. J Infect Dis. 2025 Jul 11;231(6):e1091-e1101.

Damagnez M, Walker A, Timm J. Reply to: "Reflections on HBV adaptation and immune interactions: Insights and future directions". J Hepatol. 2025 Feb 19:S0168-8278(25)00090-X.

Killer A, Gliga S, Massion P, Ackermann C, De Angelis C, Flasshove C, Freise N, Lübke N, Timm J, Eberhardt KA, Bode J, Jensen BO, Luedde T, Orth HM, Feldt T. Trajectories and predictive significance of inflammatory parameters for clinical outcome in COVID-19 patients treated with tocilizumab. Infection. 2025 Feb;53(1):339-348.

Tometten I, Brandt T, Schlotz M, Stumpf R, Landmann S, Kantauskaite M, Lamberti J, Hillebrandt J, Müller L, Kittel M, Ivens K, Gruell H, Voges A, Schaal H, Lübke N, Königshausen E, Rump LC, Klein F, Stegbauer J, Timm J.   Comparison of immune responses to SARS-CoV-2 spike following Omicron infection or Omicron BA.4/5 vaccination in kidney transplant recipients. Front Immunol. 2025 Jan 14;15:1476294. 

Schwarz T, Ptok J, Damagnez M, Menne C, Alizei ES, Lang-Meli J, Maas M, Habermann D, Hoffmann D, Schulze Zur Wiesch J, Lauer G, Kefalakes H, Cornberg M, Kraft AR, Gliga S, Bock HH, Horn PA, Maini MK, Thimme R, Wedemeyer H, Nattermann J, Heinemann FM, Luedde T, Neumann-Haefelin C, Walker A, Timm J. HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replication. J Hepatol. 2025 May;82(5):805-815.